دورية أكاديمية

Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol

التفاصيل البيبلوغرافية
العنوان: Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol
المؤلفون: Guus Grimbergen, Hidde Eijkelenkamp, Louk M.W. Snoeren, Rana Bahij, Uffe Bernchou, Erik van der Bijl, Hanne D. Heerkens, Shawn Binda, Sylvia S.W. Ng, Christelle Bouchart, Zelda Paquier, Kerryn Brown, Richard Khor, Robert Chuter, Linnéa Freear, Alex Dunlop, Robert Adam Mitchell, Beth A. Erickson, William A. Hall, Paola Godoy Scripes, Neelam Tyagi, Jeremiah de Leon, Charles Tran, Seungjong Oh, Paul Renz, Andrea Shessel, Edward Taylor, Martijn P.W. Intven, Gert J. Meijer
المصدر: Clinical and Translational Radiation Oncology, Vol 47, Iss , Pp 100797- (2024)
بيانات النشر: Elsevier, 2024.
سنة النشر: 2024
المجموعة: LCC:Medical physics. Medical radiology. Nuclear medicine
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: MR-guided SBRT, Pancreatic cancer, Treatment planning, Consensus protocol, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Background and purpose: Treatment planning for MR-guided stereotactic body radiotherapy (SBRT) for pancreatic tumors can be challenging, leading to a wide variation of protocols and practices. This study aimed to harmonize treatment planning by developing a consensus planning protocol for MR-guided pancreas SBRT on a 1.5 T MR-Linac. Materials and methods: A consortium was founded of thirteen centers that treat pancreatic tumors on a 1.5 T MR-Linac. A phased planning exercise was conducted in which centers iteratively created treatment plans for two cases of pancreatic cancer. Each phase was followed by a meeting where the instructions for the next phase were determined. After three phases, a consensus protocol was reached. Results: In the benchmarking phase (phase I), substantial variation between the SBRT protocols became apparent (for example, the gross tumor volume (GTV) D99% ranged between 36.8 – 53.7 Gy for case 1, 22.6 – 35.5 Gy for case 2). The next phase involved planning according to the same basic dosimetric objectives, constraints, and planning margins (phase II), which led to a large degree of harmonization (GTV D99% range: 47.9–53.6 Gy for case 1, 33.9–36.6 Gy for case 2). In phase III, the final consensus protocol was formulated in a treatment planning system template and again used for treatment planning. This not only resulted in further dosimetric harmonization (GTV D99% range: 48.2–50.9 Gy for case 1, 33.5–36.0 Gy for case 2) but also in less variation of estimated treatment delivery times. Conclusion: A global consensus protocol has been developed for treatment planning for MR-guided pancreatic SBRT on a 1.5 T MR-Linac. Aside from harmonizing the large variation in the current clinical practice, this protocol can provide a starting point for centers that are planning to treat pancreatic tumors on MR-Linac systems.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2405-6308
العلاقة: http://www.sciencedirect.com/science/article/pii/S2405630824000740Test; https://doaj.org/toc/2405-6308Test
DOI: 10.1016/j.ctro.2024.100797
الوصول الحر: https://doaj.org/article/071a76da20144668a7eb39a5afdc91e1Test
رقم الانضمام: edsdoj.071a76da20144668a7eb39a5afdc91e1
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:24056308
DOI:10.1016/j.ctro.2024.100797